NYSE: DPLO

-0.14 -1.01% $ 13.75 Volume: 787,467 Common Stock | 20 minute delay February 15, 2019

Improving Our Value by Improving Our Care

Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in deep specialty-pharmacy expertise, Diplomat’s innovative service model unites complementary brands to anticipate market needs, create shareholder value, and drive better patient outcomes.

Date Filing Filing Description Download
February 14, 2019 5 Annual Statement of Changes in Beneficial Ownership
February 14, 2019 SC 13G/A Amended Statement of Ownership
February 14, 2019 SC 13G Statement of Ownership

NYSE: DPLO

-0.14 -1.01% $ 13.75 Volume: 787,467 Common Stock | 20 minute delay February 15, 2019

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
tpowers@diplomat.is
Phone: 312.889.5244

Email Now